John C Jacobs Novavax Inc (NVAX) insider trading activity

NVAX Quotes by TradingView

John C Jacobs is President and CEO of NOVAVAX INC. Currently has a direct ownership of 91,849 shares of NVAX, which is worth approximately $809,189. The most recent transaction as insider was on Jan 23, 2025, when has been sold 38,873 shares (Common Stock) at a price of $9.55 per share, resulting in proceeds of $371,237. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 91.8K
113.09% 3M change
113.09% 12M change
Total Value Held $809,189

John C Jacobs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2025
SELL
Payment of exercise price or tax liability
$371,237 $9.55 p/Share
38,873 Reduced 29.74%
91,849 Common Stock
Jan 23 2025
BUY
Exercise of conversion of derivative security
-
83,196 Added 38.89%
130,722 Common Stock
Jan 23 2024
SELL
Payment of exercise price or tax liability
$170,796 $4.26 p/Share
40,093 Reduced 48.19%
43,104 Common Stock
Jan 23 2024
BUY
Exercise of conversion of derivative security
-
83,197 Added 50.0%
83,197 Common Stock

Also insider at

HRMY
Harmony Biosciences Holdings, Inc. Healthcare
PRESIDENT, CEO
JCJ

John C Jacobs

President and CEO
Plymouth Meeting, PA

Track Institutional and Insider Activities on NVAX

Follow NOVAVAX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

News

Receive news related to NOVAVAX INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NVAX